GREM1 inhibits osteogenic differentiation, senescence and BMP transcription of adipose-derived stem cells.

Connective Tissue Research
Huina LiuZhipeng Fan

Abstract

Purpose: Adipose-derived stem cells (ADSCs) are ideal for cell-based therapies to support bone regeneration. It is vital to understand the critical genes and molecular mechanisms involved in the functional regulation of ADSCs for enhancing bone regeneration. In the present study, we investigated the Gremlin 1 (GREM1) effect on ADSCs osteogenic differentiation and senescence.Materials and methods: The in vitro ADSCs osteogenic differentiation potential was evaluated by determining alkaline phosphatase (ALP) activity, mineralization ability, and the expression of osteogenic markers. Cell senescence is determined by SA-β-gal staining, telomerase assay, and the expression of aging markers.Results: GREM1 overexpression in ADSCs reduced ALP activity and mineralization, inhibited the expression of osteogenic related genes OCN, OPN, DSPP, DMP1, and BSP, and key transcription factors, RUNX2 and OSX. GREM1 knockdown in ADSCs enhanced ALP activity and mineralization, promoted the expression of OCN, OPN, DSPP, DMP1, BSP, RUNX2, and OSX. GREM1 overexpression in ADSCs reduced the percent SA-β-Gal positive cells, P16 and P53 expressions, and increased telomerase activity. GREM1 knockdown in ADSCs increased the percentage of SA-β-Gal positive ...Continue Reading

References

Mar 18, 2000·The Journal of Biological Chemistry·L Z TopolD G Blair
Jun 14, 2005·Cytokine & Growth Factor Reviews·Motoko Yanagita
Aug 20, 2005·The Journal of Biological Chemistry·Fumitaka KugimiyaUng-il Chung
Dec 27, 2006·Free Radical Biology & Medicine·Kyle E BrownDouglas R Spitz
Mar 14, 2007·British Journal of Cancer·E Hiyama, K Hiyama
Sep 6, 2007·The Journal of Biological Chemistry·Elisabetta GazzerroErnesto Canalis
Oct 16, 2007·Annals of the New York Academy of Sciences·He Li, Jun-Ping Liu
Feb 26, 2008·Expert Opinion on Biological Therapy·Froilan Granero-MoltoAnna Spagnoli
Nov 18, 2008·Cell·Antonia Tomás-LobaMaria A Blasco
Nov 11, 2009·Cytokine & Growth Factor Reviews·A Hari Reddi, Anand Reddi
Nov 17, 2010·Genes & Development·Thomas KuilmanDaniel S Peeper
Mar 18, 2011·Journal of Cellular Physiology·Ernesto CanalisStefano Zanotti
May 10, 2012·Molecules and Cells·Sohee Cho, Eun Seong Hwang
Feb 19, 2013·Oncogene·A RufiniG Melino
Mar 22, 2014·The Journal of Biological Chemistry·Sarika RayalaSathyanarayana N Gummadi
Jul 6, 2014·Progress in Molecular Biology and Translational Science·Miriam Aparecida GiardiniMaria Isabel Nogueira Cano
Dec 30, 2014·Stem Cells·Hanadie YousefDavid V Schaffer
Jan 17, 2015·Trends in Cell Biology·Derek P BrazilFinian Martin
Jun 20, 2015·Experimental Biology and Medicine·Huijuan LiuBaojie Li
Mar 17, 2016·World Journal of Biological Chemistry·Mai FujimotoAtsushi Kaneda
Mar 24, 2016·Stem Cell Research & Therapy·Emmanuel GibonStuart B Goodman
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Yohei HayashiShinya Yamanaka
Mar 7, 2017·World Journal of Experimental Medicine·Abu Shufian Ishtiaq AhmedKin-Hing William Lau
Apr 30, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Qian LiZhiming Hao
Jun 3, 2018·Nature Reviews. Molecular Cell Biology·Maria ErmolaevaK Lenhard Rudolph
Oct 26, 2018·Proceedings of the National Academy of Sciences of the United States of America·María Díaz-MorenoHelena Mira
Apr 12, 2019·Current Stem Cell Research & Therapy·Mohsen SheykhhasanAlexander M Seifalian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Genetics & Epigenetics of Aging

Dozens of genes are implicated in lifespan, and epigenetic changes during aging affect cell function. This feed focuses on the genetics and epigenetics of aging.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.